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Objective. Otitis media (OM) is characterized by increased middle ear eﬀusion and inﬂammation of middle ear tissue. In this
study, we compared two radiographic methods of analyzing inﬂammation by measuring mucosal thickness (MT). Methods.2 8
chinchillas were divided into three treatment groups consisting of a vehicle control group and two glucocorticoid groups. 6 under-
went treatment by vehicle control, 10 were treated with ciproﬂoxacin 0.3%/dexamethasone 0.1% (DEX), and 10 received cipro-
ﬂoxacin 0.2%/hydrocortisone 1% (HC). 96hrs post-LPS inoculation, chinchillas were euthanized and their temporal bones were
removed for analyses. Results. MRI scans (F = 146.0861, P-value <0.0001) and histology (χ2 = 40.5267, P-value <0.0001) revealed
statistically signiﬁcant diﬀerences in MT measurements among treatment groups, whereas CT imaging did not. DEX-treated
chinchillas exhibited overall signiﬁcantly smaller MT values. Conclusion. Imaging MT was eﬀective for determining severity of
inﬂammation due to OM. Previous gold standard methods using histopathology compromise tissue integrity by chemical mani-
pulationanddehydrationeﬀects.MRIandCTscanningareviabletoolstopreservetissueandexaminechangesinMT.Inthisstudy,
MRI provided more information about internal, soft tissue structures. In a clinical setting, MRI could be used for diagnosing and
tracking severe or chronic OM.
1.Introduction
Considerablevariationexistsintheclinicaldiagnosisofotitis
media(OM).Forthemajorityofclinicians,successfullydiag-
nosing OM is achieved from accurate otoscopic examination
in which bulging of the tympanic membrane is evidenced
along with pervasive erythema around the ear canal [1].
Traditionally, the causes of OM are classiﬁed as eustachian
tubedysfunctionorinfection[2].Consistentwithﬁndingsof
infection, increased middle ear eﬀusion (MEE) coupled with
inﬂammation of middle ear mucosa and increase of mucosal
thickness (MT) take place as part of the body’s immune
response to foreign pathogens. Unchecked, misdiagnosed, or
inappropriately treated OM can persist chronically and lead
to complications. In order to control and prevent OM prog-
ression,someimagingmodalities havebeenusedtodiagnose
and followup with treatment progression. Though there are
many imaging tools and few guidelines for their use, it does
seem that anatomic imaging vis-a-vis CT or MRI is fre-
quently favored.
In the scientiﬁc literature, MRI is often used when more
accurateviewsofsofttissueareneeded[3,4].Conversely,CT
is used to show the extent of bony changes [4]. In terms of
severe OM cases, CT use is important to identifying early
stages of disease and for assessing progression that involves
bony regions. Though MRI and CT seem to have clear delin-
eations for their use, they are frequently used concurrently
and interchangeably.
Therefore, the aim of this study was two fold:
(1) to compare two glucocorticoid treatments in order to
evaluate drug eﬀectiveness in reducing overall MT,2 International Journal of Otolaryngology
(2) toevaluateandcomparetheuseofradiographictools
(MRI and CT) in visualizing OM changes following
treatment.
The null hypothesis for this study is summarized as follows:
(H0) There is no diﬀerence in MT among treatment
groups as assessed by MRI, CT, and histology.
2. Methods
2.1. Animals. 28 chinchillas were obtained from Bowen’s
Chinchillas,LLC.Allchinchillaswereadultfemales,weighing
between 500 and 700 grams each. Upon arriving at the
VeterinaryMedicalUnit(VMU)attheJerryL.PettisVeterans
Medical Center, they were placed in isolation and observed
for one week. During this time, all chinchillas were screened
for absence of OM by anesthetizing them with isoﬂurane
(induction 3.5%, maintenance 2.5%) inhalation and eval-
uating each ear canal with a micro otoscope; they were all
conﬁrmed to be normal, healthy chinchillas, with absence of
OM at baseline. All animal procedures were approved by the
Institutional Animal Care and Use Committee at the Jerry L.
Pettis Memorial Veterans Administration Medical Center.
The 28 chinchillas were divided into three treatment
groups: 6 underwent treatment by vehicle control, 11 were
treated with Ciprodex: ciproﬂoxacin 0.3%/dexamethasone
0.1% (DEX), and 11 received Cipro HC: ciproﬂoxacin 0.2%/
hydrocortisone 1% (HC). The vehicle control was composed
of the sterile, preserved suspension used to make Ciprodex
and Cipro HC and was obtained from Alcon, Inc. This was
selected as a control solution over other potential control
substances,suchassaline,becauseitremainsassimilartothe
treatmentgroups,butwithoutantibioticsorsteroidspresent.
The composition for the vehicle control includes benzalko-
nium chloride as a preservative, boric acid, sodium chloride,
hydroxyethylcellulose,tyloxapol,aceticacid,sodiumacetate,
edetate disodium, and puriﬁed water.
Ciprodex (ciproﬂoxacin 0.3% and dexamethasone 0.1%;
NDC number 0065-8533-02) was obtained as a sterile otic
suspension. It is a combination antibiotic (quinolone), ster-
oid treatment commonly used by clinicians to treat acute
otitis externa and acute OM following tympanostomy tube
placement or with tympanic membrane perforation. Cipro-
dex confers broad-spectrum antibiotic protection with low
adverse eﬀects and minimal ototoxicity.
Cipro HC (ciproﬂoxacin 0.2% HCl and hydrocortisone
1%; NDC number 0065-8531-10) was also obtained as a
sterile otic suspension. Similarly, it is a broad-spectrum anti-
biotic, steroid treatment.
Ciprodex and Cipro HC are registered trademarks of
Bayer AG licensed to Alcon, Inc. and are available by pre-
scription only. Their compositions are akin with the under-
lying diﬀerence being the anti-inﬂammatory corticosteroid:
DEX versus HC.
2.2. Procedure. Chinchillas were injected via the superior
bullae with 0.2mL of their respective treatment. Two hours
later, chinchillas were inoculated with 0.3mL of Salmonella
enteric lipopolysaccharide (LPS)andadditional 0.2mLtreat-
ments of respective treatments were injected into the inferior
bullae at 24, 48, and 72hrs after LPS inoculation. At 120hrs
postinoculation,chinchillaswereeuthanizedusingan80mg/
kg ketamine intramuscular injection. Following animal sac-
riﬁce, chinchilla temporal bones were preserved in 10% for-
malin for 72hrs, then washed in 10x PBS, and ﬁnally stored
in 10x PBS, 0.1% azide at 3◦C.
2.3. Radiographic Imaging
MRI. 18 intact chinchilla temporal bones were taken to the
Non-Invasive Imaging Laboratory at Loma Linda University
and imaged using Brucker MRI 11.7T, which produced T-2
weightedimages(ﬁeldofview=3cm;slicethickness=1mm;
interslice distance = 1mm; number of slices = 30; num-
ber of echoes = 10; matrix = 256×256; resolution read =
0.0117cm/pixel; repetition; time = 3593.9ms; echo time =
10.2ms; slice orientation = sagittal) (Figure 1). Temporal
bones were dried before imaging processes to reduce eﬀects
ofwater.MRIimageswereviewedandanalyzedusingChesh-
ire v4.3 software, where MT was measured using the ruler
tool which produced measures in pixels. MT was then cal-
culated into mm given that 1 pixel is equivalent to 0.117mm.
10-11 MT measures were calculated per specimen for 36
chinchilla middle ears (18 temporal bones × 2s i d e s= 36
middle ear cavities), providing an N = 380 data points.
Given that the MRI was T2 weighted, soft tissue MT in the
inferior bullae appear bright white against empty space,
bone, and residual water, which appears black (Figure 2).
CT. 14 middle ear cavities that were MRI imaged were taken
to the VMU at the Jerry L. Pettis Veterans Medical Center for
imaging using Scanco vivaCT 40 (slice thickness=10.5 mi-
crons; number of slices=140). Due to the fact that the speci-
mens were half of the MRI imaged samples (see Figure 1), a
radiographicpinwasinsertedintotheinferiorbullaetofacil-
itate CT imaging and maintain imaging consistency. Once
again, specimen were dried before imaging processes to re-
duceeﬀectsofwater.ImageswereanalyzedusingScancosoft-
ware. MT was measured in two ways: bone-to-mucus ratio,
andmucosalvolume.Intheimages,bonesappearswhiteand
MT appears gray (Figure 2).
2.4. Histology. Following radiographic imaging, all chin-
chilla specimens were decalciﬁed using 3M EDTA over a
four-week period with 3 EDTA changes. Following decalci-
ﬁcation, specimens were further reduced to a quarter of their
original size (see Figure 1) and placed in a paraﬃn processor
overnight. Paraﬃn-embedded samples were sectioned at 15
microns over approximately the bottom-most 6mm area
of the inferior bullae. Sections were later stained by H&E
and analyzed using an Olympus biological microscope with
digital camera DP72. The DP72 computer software was used
for image capture. MT measures were made in Adobe PDF
Converter Professional oﬀ the images at unit length mm. In
the histology images, decalciﬁed bone is the lower pink layer,
andMTisthemiddle andupperlayers,appearing asalighter
pink/darker purple layer (Figure 2).International Journal of Otolaryngology 3
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Figure 1: Description of specimen use. Each specimen began with a complete chinchilla skull, which was used for MRI imaging. Due to
the size limitation of samples in the Micro-CT machine, chinchilla skulls were halved to accommodate CT imaging. Once imaging was
completed, samples were further pared down to about one quarter of their original size for histology processing. Histology cassettes and
molds limited the size of the sample.
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Figure 2: Imaging results compared by treatment group. Under the T2-weighted MRI produced images of MT that appear bright white for
both right and left inferior bullae, whereas the dark space represents bone and/or air. The CT images were made for either the right or left
bullae, with the bottom quadrant was targeted to match the MRI area that was measured. In the CT imaging, white represents moist MT. In
the third column, histology images are presented, where MT demarcation is indicated by the arrow, and the bright pink outside the arrow
bounds represents bone.
Table 1: Tukey’s followup analysis for MRI measures of MT. MT measures across treatment grouping show that DEX was successful at
reducing MT values when compared to both control and HC treated groups.
MT measures by MRI imaging α = 0.05
Treatment comparison Diﬀerence between means Conﬁdence limits
Control-HC 2.31 −1.199, 5.819
Control-DEX 24.678 21.169, 28.188
HC-Control −2.31 −5.819, 1.199
HC-DEX 22.368 19.776, 24.96
DEX-Control −24.678 −28.188, −21.169
DEX-HC −22.368 −24.960, −19.7764 International Journal of Otolaryngology
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Boxplot of mucosal thickness by treatment—MRI imaging
Figure 3: Boxplot of mucosal thickness by MRI Imaging. While there are some outliers present in the HC and control groups, the overall
relationship of MT measures across treatment groups is statistically diﬀerent, with DEX exhibiting signiﬁcant MT reduction (N = 380,
α = 0.05, F = 146.0861, P-value <0.0001). MRI MT measures were based in millimeters (mm).
Table 2:Tukey’sfollowupanalysisforHistologymeasuresofMT.HistologyconﬁrmedMRIresultsforDEXeﬃcacyatreducingMT.Though
HC was eﬀective at reducing MT when compared to control alone, the diﬀerence was not statistically signiﬁcant. Only DEX signiﬁcantly
reduced MT compared to both HC and control treatment groups. The diﬀerences between means reported by histology are similar to
those reported by MRI but seem smaller in magnitude. This may be attributed to histoprocesses that compromise tissue integrity (i.e., MT
desiccation due to various chemical changes, other eﬀects on MT resulting from paraﬃn impregnation, etc.). Diﬀerences in histology and
MRI ﬁndings could also result from a diﬀerence in sample siza. N = 380 for MRI and N = 194 for histology.
MT measures by Histology α = 0.05
Treatment comparison Diﬀerence between means Conﬁdence limits
Control-HC 0.121 −0.17271, 0.415
Control-DEX 0.690 0.40969, 0.971
HC-Control −0.121 -0.41537, 0.173
HC-DEX 0.569 0.33475, 0.803
DEX-Control −0.690 −0.97086, −0.410
DEX-HC −0.569 −0.80314, −0.335
2.5.Statistics. SAS9.1wasusedtoanalyzesigniﬁcanceofMT
values and produce boxplots. Microsoft Excel was used to
generate bar charts and tables.
3. Results
MRI MT values were evaluated by treatment groups. The
dataset consisted of N = 380 data points, with an overall
and treatment group stratiﬁed distribution that appeared
normal. ANOVA testing produced statistically diﬀerent mea-
suresofMTamongtreatmentgroups(F = 146.0861,P-value
<0.0001) (Figure 3). Post-hoc testing by Tukey revealed sig-
niﬁcant (α = 0.05) mean diﬀerences between treatment
groups (Table 1). Box-plots and bar charts were created to
represent the ﬁndings (Figures 3 and 6).
CT MT values were also evaluated by treatment groups.
The dataset was smaller, with an N = 14. The overall and
group stratiﬁed distribution was grossly nonparametric.
Kruskal-Wallis was used to analyze global diﬀerences across
treatment groups but did not ﬁnd any statistical signiﬁcance
when analyzing bone to mucosal thickness ratios (χ2 =
1.2404, P-value = 0.5378) and total average calculated mu-
cosal volume (χ2 = 0.9762, P-value=0.6138). Box-plots and
bar charts were generated to show trends, but no additional
post-hoc testing was conducted (Figures 4 and 7).
HistologyMTvalueswereevaluatedbytreatmentgroups.
The dataset consisted of N = 194 measures. The overall and
group stratiﬁed distributions were nonnormative. Kruskal-
W a l l i sw a su s e dt oe v a l u a t ed i ﬀerence across treatment
groups and revealed a signiﬁcant ﬁnding (χ2 = 40.5267,
P-value<0.0001). Post-hoc testing with Tukey was conduc-
tedonthedataandshowedstatisticallysigniﬁcantdiﬀerences
(α = 0.05) between groups (Table 2). Box-plots and bar
charts were made to show these diﬀerences graphically
(Figures 5 and 6).
For both MRI and histology ﬁndings DEX-treated sam-
ples exhibited reduced MT compared to HC-treated and
vehicle control subjects.
4. Discussion
Previousresearchinvestigating OMfound thatdiagnosis and
prognosis using anatomical imaging such as CT and MRI
were preferred over nuclear medicine approaches. Further-
more, researchers found that by comparison to CT, MRI wasInternational Journal of Otolaryngology 5
6
7
8
5
4
3
2
DEX HC Control
Treatment
Boxplot of mucosal volume by treatment—CT imaging
M
u
c
o
s
a
l
 
v
o
l
u
m
e
 
(
m
m
3
)
Figure 4:BoxplotofmucosalthicknessbyCTImaging.Findingsby
CT also reveal that DEX treated chinchillas had less MT thickness
when compared to the other groups. While the overall trend is
comparable to the MRI and Histology results, the CT ﬁndings are
not statistically signiﬁcant at an α = 0.05 level due to the small
sample size (N = 14, χ2 = 0.9762, P-value = 0.6138). CT measures
of MT were based on mucosal volume (mm3).
better at exploring soft tissue changes over time [4]. Simi-
larly, an investigation into chronic OM aﬀecting the temp-
oro-mandibular joint found the utility of MRI for imaging
intracranial soft tissue masses and thrombosis of sinus tran-
versus to evaluate mastoiditis prior to therapeutic surgical
techniques [5]. In this same study, investigators also used
CT to reveal anatomical changes in bone and surrounding
soft tissue mass but found that MRI provided more detailed
analyses of infection severity by imaging soft tissue swelling
[5].UnoﬃcialconsensusfavorsMRIforitscosteﬀectiveness,
availability, high resolution, image detail, and absence of
radioactivity [6].
In this investigation, we found additional support for
MRI use in imaging inﬂammation and speciﬁcally for track-
ing OM by means of MT. Our MRI data were easy to extract
and analyze, producing an adequate sample size estimation
of MT outcomes across groups. Our CT data were based
on a relatively smaller sample size due to imaging demands
and resources. CT results were somewhat harder to evaluate
because of the high bone resolution and lower resolution
mucosal layer. Given that our MRI and CT data were not
exactly comparable, and previous reviews have commented
on the inaccuracy of imaging OM [7], histology served as the
point of reference. From histology results, we are able to con-
ﬁrm the utility of MRI for imaging MT as an inﬂammatory
marker of OM. For future investigations, however, contrast
enhanced MRI-imaging of in-vivo, inoculated specimen
would provide greater detail of OM processes and changes
over time; in-vivo imaging practices would parallel clinical
manifestations more accurately.
This investigation also highlighted the promising role
of DEX for improving inﬂammation of OM. MT measures
across treatment groups using all analytic methods (MRI,
CT, and histology) showed that DEX was more eﬀective
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Figure 5: Boxplot of mucosal thickness by Histology. Histology
results also show the reduced MT in the DEX-treated specimen
compared to the other treatment groups. The ﬁndings were sta-
tistically signiﬁcant (N = 194, α = 0.05. χ2 = 40.5267, P-value
<0.0001). Histology measures of MT were made in millimeters
(mm).
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Figure 6: Measuring MT by MRI and Histology. This bar chart is a
comparisonoftwomethodsformeasuringMT,whichshowcompa-
rable ﬁndings. Both MRI and Histology methods reveal that DEX-
treatedchinchillasproducedlessmucosalthicknesswhencompared
to HC-treated and control groups. The disparity in the MT thick-
ness is likely due to the specimen handling during histology, which
requires use of various desiccating substances.
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Figure 7: Measuring MT by CT. Measuring mucosal thickness by
CT imaging produced measures of MT volume, which is why this
bar chart stands alone. The ﬁndings, however, are similar to those
observed in Figure 6, where DEX-treated chinchillas had less MT
thickness compared to the other treatment groups.6 International Journal of Otolaryngology
at decreasing MT. The use of DEX in combination with
antibiotics seems to be a more eﬀective treatment to reduce
inﬂammation in the middle ear. MRI seems to be a better
imaging method of determining stage and severity of acute
or chronic OM.
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